U.S. Food and Drug Administration Coronavirus Update

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

The FDA recently issued an emergency use authorization (EUA) for a blood purification system to treat patients 18 years of age or older with confirmed COVID-19 Coronavirus admitted to the intensive care unit with confirmed or imminent respiratory failure.

[Read more]

Coronavirus (COVID-19) Update: FDA Issues Second Emergency Use Authorization to Decontaminate N95 Respirators

Silver Spring, MD – The U.S. Food and Drug Administration issued the second emergency use authorization (EUA) to decontaminate compatible N95 or N95-equivalent respirators for reuse by health care workers in hospital settings. This EUA will support decontamination of approximately 750,000 N95 respirators per day in the U.S.

[Read more]

By the Numbers: A Massive Nationwide Response

Washington, D.C. – When the world has faced trying times, Americans have never failed to rise to the occasion. The Coronavirus (COVID-19) pandemic is and will be no exception.
 
U.S. Sparing no expense to win this fight
 
“We have the best doctors, the best military leaders, and the best logistics professionals anywhere in the world,” President Donald Trump said yesterday. “And we’re orchestrating a massive federal response unlike anything our country has ever seen or done.”

[Read more]